Molbio Diagnostics Share Price Today

Kotak Mahindra Mutual Fund crosses 5% stake in Molbio Diagnostics

Kotak Mahindra Mutual Fund acquired 570,000 shares of Molbio Diagnostics on October 8, 2026. Total holding rose to 6,319,083 shares, representing 5.4834% of voting capital. Acquisition was made through open market transactions under SAST Regulation 29(1). Previous holding stood at 4.9888%, indicating a marginal breach of the 5% threshold.

India Business Excellence Fund III sells 2.06% stake in Molbio Diagnostics

India Business Excellence Fund III sold 23,77,627 shares of Molbio Diagnostics on September 30, 2026. The transaction reduced the fund's stake from 8.92% to 6.85% of total voting capital. The sale was executed via open market and triggered disclosure under SEBI Regulation 29(2). Total equity share capital of the company remains unchanged at 11,52,39,996 shares.

Molbio Diagnostics shares worth ₹305.42 crore change hands on BSE

Approximately 22,32,574 Molbio Diagnostics shares changed hands on BSE at ₹1,315.00 per share. Combined value of the flagged activity stands at ₹305.42 crore. This is a real-time large-trade signal and not a confirmed exchange-reported event. Official exchange disclosures on such activity are published only after market close.

Molbio Diagnostics sees corrected stake exit disclosure by India Business Excellence Fund

India Business Excellence Fund III sold 30,00,000 Molbio Diagnostics shares on September 23, 2026. Stake reduced from 11.52% to 8.92%, breaching the 2% SEBI SAST threshold. Corrigendum filed on September 24, 2026, to correct clerical errors in the original disclosure. Transaction executed via open market with no encumbered shares involved.

Molbio Diagnostics reappoints K.S. Kamalakara & Co as cost auditors for FY27

Molbio Diagnostics reappointed M/s K. S. Kamalakara & Co as cost auditors for FY27. The firm is based in Bengaluru and holds Firm Registration No. 000296. Board approved the reappointment on September 25, 2026. CMA K. S. Kamalakara leads the firm with over two decades of experience.

Molbio Diagnostics shares worth ₹365.64 crore flag large-trade signal

Approximately 27,80,549 Molbio Diagnostics shares changed hands on BSE, flagged as a large-trade signal. The shares traded at ₹1,315.00 per share, for a combined value of ₹365.64 crore. This is a real-time signal from a trade-scanning system, not a confirmed exchange-level event. Buyer, seller, and client identities are not known; official disclosures are made by the exchange only after market close.